New COVID-19 vaccines considered effective against the omicron variant will be available to all people who have completed at least two inoculations from as early as mid-October, the government said Monday.
The bivalent vaccines, so named for their combination of ingredients deriving from existing COVID-19 shots and from omicron’s BA.1 subvariant, have been reported to provide some increase in neutralizing antibodies against the BA.5 subtype currently prevalent across the country.
In a time of both misinformation and too much information, quality journalism is more crucial than ever.
By subscribing, you can help us get the story right.